United States Prophylactic Human Vaccine Market Research Report Forecast 2017-2021

April 2017 | 107 pages | ID: U01F972EA78EN
S&P Consulting

Abstracts

The United States Prophylactic Human Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prophylactic Human Vaccine industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prophylactic Human Vaccine market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer

United States Prophylactic Human Vaccine Market: Product Segment Analysis
Type 1
Type 2
Type 3

United States Prophylactic Human Vaccine Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PROPHYLACTIC HUMAN VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Prophylactic Human Vaccine Market Segmentation by Type
  1.2.1 United States Production Market Share of Prophylactic Human Vaccine by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Prophylactic Human Vaccine Market Segmentation by Application
  1.3.1 Prophylactic Human Vaccine Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Prophylactic Human Vaccine (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON PROPHYLACTIC HUMAN VACCINE INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES PROPHYLACTIC HUMAN VACCINE MARKET COMPETITION BY MANUFACTURERS

3.1 United States Prophylactic Human Vaccine Production and Share by Manufacturers (2015 and 2016)
3.2 United States Prophylactic Human Vaccine Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Prophylactic Human Vaccine Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Prophylactic Human Vaccine Manufacturing Base Distribution, Production Area and Product Type
3.5 Prophylactic Human Vaccine Market Competitive Situation and Trends
  3.5.1 Prophylactic Human Vaccine Market Concentration Rate
  3.5.2 Prophylactic Human Vaccine Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES PROPHYLACTIC HUMAN VACCINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Prophylactic Human Vaccine Production and Market Share by Type (2012-2017)
4.2 United States Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Prophylactic Human Vaccine Price by Type (2012-2017)
4.4 United States Prophylactic Human Vaccine Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES PROPHYLACTIC HUMAN VACCINE MARKET ANALYSIS BY APPLICATION

5.1 United States Prophylactic Human Vaccine Consumption and Market Share by Application (2012-2017)
5.2 United States Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES PROPHYLACTIC HUMAN VACCINE MANUFACTURERS ANALYSIS

6.1 Bavarian Nordic A/S
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 BiondVax Pharmaceuticals Ltd
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Bharat Biotech International Limited
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 GlaxoSmithKline
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Hualan Biological Engineering
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Janssen Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 MedImmune
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Merck
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Pfizer
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 PROPHYLACTIC HUMAN VACCINE MANUFACTURING COST ANALYSIS

7.1 Prophylactic Human Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prophylactic Human Vaccine

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prophylactic Human Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES PROPHYLACTIC HUMAN VACCINE MARKET FORECAST (2017-2021)

11.1 United States Prophylactic Human Vaccine Production, Revenue Forecast (2017-2021)
11.2 United States Prophylactic Human Vaccine Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Prophylactic Human Vaccine Production Forecast by Type (2017-2021)
11.4 United States Prophylactic Human Vaccine Consumption Forecast by Application (2017-2021)
11.5 Prophylactic Human Vaccine Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Human Vaccine
Table Classification of Prophylactic Human Vaccine
Figure United States Sales Market Share of Prophylactic Human Vaccine by Type in 2015
Table Application of Prophylactic Human Vaccine
Figure United States Sales Market Share of Prophylactic Human Vaccine by Application in 2015
Figure United States Prophylactic Human Vaccine Sales and Growth Rate (2011-2021)
Figure United States Prophylactic Human Vaccine Revenue and Growth Rate (2011-2021)
Table United States Prophylactic Human Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States Prophylactic Human Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prophylactic Human Vaccine Sales Share by Manufacturers
Figure 2016 Prophylactic Human Vaccine Sales Share by Manufacturers
Table United States Prophylactic Human Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States Prophylactic Human Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prophylactic Human Vaccine Revenue Share by Manufacturers
Table 2016 United States Prophylactic Human Vaccine Revenue Share by Manufacturers
Table United States Market Prophylactic Human Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prophylactic Human Vaccine Average Price of Key Manufacturers in 2015
Figure Prophylactic Human Vaccine Market Share of Top 3 Manufacturers
Figure Prophylactic Human Vaccine Market Share of Top 5 Manufacturers
Table United States Prophylactic Human Vaccine Sales by Type (2012-2017)
Table United States Prophylactic Human Vaccine Sales Share by Type (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by Type in 2015
Table United States Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
Table United States Prophylactic Human Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prophylactic Human Vaccine by Type (2012-2017)
Table United States Prophylactic Human Vaccine Price by Type (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Prophylactic Human Vaccine Sales by Application (2012-2017)
Table United States Prophylactic Human Vaccine Sales Market Share by Application (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Market Share by Application in 2015
Table United States Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Prophylactic Human Vaccine Sales Growth Rate by Application (2012-2017)
Table Bavarian Nordic A/S Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bavarian Nordic A/S Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Bavarian Nordic A/S Prophylactic Human Vaccine Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Market Share (2012-2017)
Table Bharat Biotech International Limited Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bharat Biotech International Limited Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited Prophylactic Human Vaccine Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Prophylactic Human Vaccine Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hualan Biological Engineering Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Prophylactic Human Vaccine Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Market Share (2012-2017)
Table MedImmune Basic Information, Manufacturing Base, Production Area and Its Competitors
Table MedImmune Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Prophylactic Human Vaccine Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Prophylactic Human Vaccine Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Prophylactic Human Vaccine Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure Prophylactic Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
Table Major Buyers of Prophylactic Human Vaccine
Table Distributors/Traders List
Figure United States Prophylactic Human Vaccine Production and Growth Rate Forecast (2017-2021)
Figure United States Prophylactic Human Vaccine Revenue and Growth Rate Forecast (2017-2021)
Table United States Prophylactic Human Vaccine Production Forecast by Type (2017-2021)
Table United States Prophylactic Human Vaccine Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur SA
Serum Institute of India Pvt
Shanghai BravoBio